Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,811 | -18,281 | -9,632 | N/A | N/A |
| Depreciation Amortization | 51 | 47 | 44 | N/A | N/A |
| Accounts payable and accrued liabilities | 441 | 674 | 609 | N/A | N/A |
| Other Working Capital | 4,079 | 593 | 662 | N/A | N/A |
| Other Operating Activity | 2,198 | -549 | -609 | 0 | 0 |
| Operating Cash Flow | $-27,042 | $-17,516 | $-8,926 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | -3 | -111 | N/A | N/A |
| Investing Cash Flow | $-128 | $-3 | $-111 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 96,295 | 51 | 3 | N/A | N/A |
| Other Financing Activity | 50,575 | 22,732 | 8,994 | 0 | 0 |
| Financing Cash Flow | $146,870 | $22,783 | $8,997 | $N/A | $N/A |
| Beginning Cash Position | 8,066 | 2,802 | 2,842 | N/A | N/A |
| End Cash Position | 127,766 | 8,066 | 2,802 | N/A | N/A |
| Net Cash Flow | $119,700 | $5,264 | $-40 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,042 | -17,516 | -8,926 | N/A | N/A |
| Capital Expenditure | -128 | -3 | -111 | N/A | N/A |
| Free Cash Flow | -27,170 | -17,519 | -9,037 | 0 | 0 |